Research Article

Direct-acting Antiviral Agents in Patients with Chronic Hepatitis C: Real-life Data
  • Ayhan Balkan
  • Yasemin Balkan
  • Abdullah Emre Yıldırım
  • Buğra Tolga Konduk
  • Sezgin Barutçu
  • Abdülkadir Daldal
  • Kenan Uğurlu
  • Mustafa Seyyar
  • Mustafa Namıduru
  • Taylan Metin
  • Murat Taner Gülşen
Viral Hepat J 2021; 27: 42-48 DOI: 10.4274/vhd.galenos.2021.2020-11-1
Evaluation of Direct-acting Antiviral Agents and Clinical Responses in Chronic Hepatitis C Patients
  • Esra Zerdalı
  • İnci Yılmaz Nakir
  • Filiz Pehlivanoğlu
Viral Hepat J 2022; 28: 79-84 DOI: 10.4274/vhd.galenos.2022.2022-4-2
Clinical Efficacy and Safety of Direct-Acting Antivirals in Chronic Hepatitis C Treatment: Real-World Data
  • Ayla Doğrugörün
  • Elif Doyuk Kartal
  • Saygın Nayman Alpat
Viral Hepat J 2023; 29: 95-100 DOI: 10.4274/vhd.galenos.2023.2023-6-1
Efficacy of Direct-acting Antivirals in Hemodialysis Patients with Chronic Hepatitis C: A Real-life Retrospective Study
  • Nurten Nur Aydın
  • Firdevs Aksoy
  • İlknur Yavuz
  • Serap İskender
  • Arzu Altunçekiç Yıldırım
  • İlknur Esen Yıldız
  • İftihar Köksal
Viral Hepat J 2019; 25: 105-108 DOI: 10.4274/vhd.galenos.2019.2019.0025
The Treatment of Ledipasvir/Sofosbuvir in Patients with Chronic Hepatitis C Virus: The Results of Five-year Follow-up
  • Murat Pekgöz
  • Nevin İnce
Viral Hepat J 2021; 27: 124-130 DOI: 10.4274/vhd.galenos.2021.2021-6-1

Case Report

Failure of Direct-Acting Antiviral Agents Due to Incomplete Hepatitis C Virus Genotyping
  • Esragül AKINCI
  • Esra YURDCU
  • Bahadır ORKUN ÖZBAY
  • Hürrem BODUR
Viral Hepat J 2018; 24: 96-98 DOI: 10.4274/vhd.2018.0022